🎁 Black Friday: up to 50% off of annual plans
D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea flag South Korea · Delayed Price · Currency is KRW
33,900
-3,500 (-9.36%)
Nov 20, 2026, 3:30 PM KST

D&D Pharmatech Revenue

D&D Pharmatech had revenue of 662.06M KRW in the quarter ending June 30, 2026, a decrease of -28.39%. This brings the company's total for the last twelve months to 2.75B, down -70.53% year-over-year. In the year 2025, D&D Pharmatech had annual revenue of 4.30B, down -62.42%. That makes D&D Pharmatech the 42,371st largest company in the world by revenue and 2,571st in South Korea.

Revenue (ttm)
2.75B
Revenue Growth
-70.53%
P/S Ratio
564.96
Revenue / Employee
110.02M
Employees
25
Market Cap
1.55T

Revenue Chart

Revenue by Geography

  • USA 3.78B 88.0%
  • China 515.11M 12.0%
Fiscal year ended Dec 31, 2025 See the full D&D Pharmatech breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.30B-7.14B-62.42%
Dec 31, 202411.44B-7.24B-38.77%
Dec 31, 202318.68B18.07B2,958.97%
Dec 31, 2022610.57M-753.54M-55.24%
Dec 31, 20211.36B--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Chabiotech1.31T
SK bioscience690.95B
Hugel471.19B
HLB Co., Ltd.101.34B
LigaChem Biosciences71.90B
ABL Bio34.28B
OliX Pharmaceuticals13.64B
Peptron6.00B
Revenue Rankings